# Vera Therapeutics (VERA) — Earnings

VERA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/vera/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$1.20 |
| EPS estimate | −$0.82 |
| EPS surprise | −46.06% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 5, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1831828/000095017025103022/vera-20250630.htm) |

Vera Therapeutics' latest reported quarter in the table is Q2 2025, reported on August 5, 2025. The company lost $1.20 per share, a wider loss than the $0.82 estimate, for a 46.06% miss. The table shows no revenue and no revenue estimate. A year earlier, in Q2 2024, the loss was $0.62 per share, so the loss nearly doubled.

Vera has posted a loss in every one of the 18 quarters shown. Annual losses were $13.71 per share in 2021, driven by a $12.23 loss in Q1 2021, then $3.34 in 2022, $2.25 in 2023 and $2.75 in 2024. The first half of 2025 totals a loss of $2.01, about 70% larger than the $1.18 a year earlier. Losses widened in each of the last four quarters compared with the same quarter a year before. Against estimates, results came in worse than forecast 12 times and better 6 times over the 18 quarters.

The table holds no results after Q2 2025. In earlier years Vera reported Q3 between November 7 and November 10, and Q4 in late February or March. A newer report will show whether the per-share loss keeps widening and whether the company records revenue.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 5, 2025 | −$0.82 | −$1.20 | -46.06% | — | — |
| Q1 2025 | May 6, 2025 | −$0.74 | −$0.81 | -9.27% | — | — |
| Q4 2024 | Feb 26, 2025 | −$0.81 | −$0.72 | 11.35% | — | — |
| Q3 2024 | Nov 7, 2024 | −$0.64 | −$0.85 | -33.33% | — | — |
| Q2 2024 | Aug 8, 2024 | −$0.56 | −$0.62 | -10.71% | — | — |
| Q1 2024 | May 9, 2024 | −$0.53 | −$0.56 | -5.58% | — | — |
| Q4 2023 | Mar 20, 2024 | −$0.50 | −$0.54 | -6.99% | — | — |
| Q3 2023 | Nov 9, 2023 | −$0.52 | −$0.45 | 13.24% | — | — |
| Q2 2023 | Aug 10, 2023 | −$0.65 | −$0.46 | 29.60% | — | — |
| Q1 2023 | May 11, 2023 | −$0.57 | −$0.80 | -40.62% | — | — |
| Q4 2022 | Mar 28, 2023 | −$0.86 | −$1.17 | -35.31% | — | — |
| Q3 2022 | Nov 9, 2022 | −$0.70 | −$0.91 | -30.02% | — | — |
| Q2 2022 | Aug 10, 2022 | −$0.68 | −$0.55 | 18.91% | — | — |
| Q1 2022 | May 16, 2022 | −$0.63 | −$0.71 | -12.11% | — | — |
| Q4 2021 | Mar 24, 2022 | −$0.45 | −$0.79 | -74.28% | — | — |
| Q3 2021 | Nov 10, 2021 | −$0.69 | −$0.36 | 47.58% | — | — |
| Q2 2021 | Aug 16, 2021 | −$0.39 | −$0.33 | 15.38% | — | — |
| Q1 2021 | Jun 24, 2021 | −$1.95 | −$12.23 | -528.79% | — | — |

## Frequently Asked Questions

### When did Vera Therapeutics (VERA) last report earnings?

Vera Therapeutics last reported on Aug 5, 2025, covering fiscal Q2 2025.

### Did VERA beat earnings estimates?

No. Vera Therapeutics reported EPS of −$1.20 for Q2 2025 against a −$0.82 estimate — a 46.06% miss.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).